BIOPHYTIS - Daily - Technical analysis published on 08/03/2022 (GMT)
- 150
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Slightly bearish
Technical indicators
67%
6%
28%
My opinion
Bullish above 0.1038 EUR
My targets
0.1361 EUR (+16.32%)
0.2432 EUR (+107.86%)
My analysis
The current short-term bullish trend is expected to quickly reset the neutral or bullish trend. To avoid contradicting the short term, it would be possible to favour long positions (at the time of purchase) for BIOPHYTIS as long as the price remains well above 0.1038 EUR. The buyers' bullish objective is set at 0.1361 EUR. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 0.2432 EUR. If there is any crossing, the next objective would be the resistance located at 0.3935 EUR. As the basic trend is not clearly displayed, attention should be paid to the price reaction to the resistance at 0.1361 EUR. On this resistance, against the trend traders who would like to go short on BIOPHYTIS with a bearish signal from their trading strategy, should not hesitate to act.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
2.3
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
BIOPHYTIS rating 0.1170 EUR. The price has increased by +38.30% since the last closing and was between 0.0850 EUR and 0.1180 EUR. This implies that the price is at +37.65% from its lowest and at -0.85% from its highest.0.0850
0.1180
0.1170
A bullish gap was detected at the opening by the Central Gaps scanner. There are a lot of buyers and they have the upper hand in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of BIOPHYTIS indicates that the overall trend is slightly bearish. Only 57.14% of the signals given by moving averages are bearish. This slightly bearish trend could quickly be reversed due to the strong bullish signals currently being given by short-term moving averages. The Central Indicators scanner detects bullish signals on moving averages that could impact this trend:
Bullish trend reversal : Moving Average 20
Type : Bullish
Timeframe : Daily
Bullish trend reversal : adaptative moving average 20
Type : Bullish
Timeframe : Daily
Moving Average bullish crossovers : AMA20 & AMA50
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 50
Type : Bullish
Timeframe : Daily
The technical indicators are bullish. There is still some doubt about the price increase.
But beware of excesses. The Central Indicators scanner currently detects this:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : Daily
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Weekly
SuperTrend indicator bullish reversal
Type : Bullish
Timeframe : Daily
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
For a small rebound in the very short term, the Central Candlesticks scanner currently notes the presence of these bullish patterns in Japanese candlesticks:
White line without lower shadow
Type : Bullish
Timeframe : Daily
Upside gap
Type : Bullish
Timeframe : Daily
Long white line
Type : Bullish
Timeframe : Daily
ProTrendLines
S1
R1
R2
R3
Price
| S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|
| ProTrendLines | 0.0813 | 0.1170 | 0.1361 | 0.2432 | 0.3935 |
| Change (%) | -30.51% | - | +16.32% | +107.86% | +236.32% |
| Change | -0.0357 | - | +0.0191 | +0.1262 | +0.2765 |
| Level | Intermediate | - | Minor | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0804 | 0.0813 | 0.0829 | 0.0838 | 0.0854 | 0.0863 | 0.0879 |
| Camarilla | 0.0839 | 0.0841 | 0.0844 | 0.0846 | 0.0848 | 0.0851 | 0.0853 |
| Woodie | 0.0809 | 0.0815 | 0.0834 | 0.0840 | 0.0859 | 0.0865 | 0.0884 |
| Fibonacci | 0.0813 | 0.0822 | 0.0828 | 0.0838 | 0.0847 | 0.0853 | 0.0863 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0717 | 0.0738 | 0.0779 | 0.0800 | 0.0841 | 0.0862 | 0.0903 |
| Camarilla | 0.0802 | 0.0808 | 0.0813 | 0.0819 | 0.0825 | 0.0830 | 0.0836 |
| Woodie | 0.0726 | 0.0743 | 0.0788 | 0.0805 | 0.0850 | 0.0867 | 0.0912 |
| Fibonacci | 0.0738 | 0.0762 | 0.0777 | 0.0800 | 0.0824 | 0.0839 | 0.0862 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0541 | 0.0650 | 0.0735 | 0.0844 | 0.0929 | 0.1038 | 0.1123 |
| Camarilla | 0.0766 | 0.0783 | 0.0801 | 0.0819 | 0.0837 | 0.0855 | 0.0872 |
| Woodie | 0.0528 | 0.0644 | 0.0722 | 0.0838 | 0.0916 | 0.1032 | 0.1110 |
| Fibonacci | 0.0650 | 0.0724 | 0.0770 | 0.0844 | 0.0918 | 0.0964 | 0.1038 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 75.56 | |
| MACD (12,26,9): | -0.0023 | |
| Directional Movement: | 30.7635 | |
| AROON (14): | 50.0000 | |
| DEMA (21): | 0.0805 | |
| Parabolic SAR (0,02-0,02-0,2): | 0.0780 | |
| Elder Ray (13): | 0.0141 | |
| Super Trend (3,10): | 0.0794 | |
| Zig ZAG (10): | 0.1099 | |
| VORTEX (21): | 1.0269 | |
| Stochastique (14,3,5): | 84.46 | |
| TEMA (21): | 0.0874 | |
| Williams %R (14): | -14.14 | |
| Chande Momentum Oscillator (20): | 0.0288 | |
| Repulse (5,40,3): | 27.9934 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -0.9986 | |
| Courbe Coppock: | 15.85 |
| MA7: | 0.0854 | |
| MA20: | 0.0818 | |
| MA50: | 0.0998 | |
| MA100: | 0.1418 | |
| MAexp7: | 0.0882 | |
| MAexp20: | 0.0865 | |
| MAexp50: | 0.1044 | |
| MAexp100: | 0.1603 | |
| Price / MA7: | +37.00% | |
| Price / MA20: | +43.03% | |
| Price / MA50: | +17.23% | |
| Price / MA100: | -17.49% | |
| Price / MAexp7: | +32.65% | |
| Price / MAexp20: | +35.26% | |
| Price / MAexp50: | +12.07% | |
| Price / MAexp100: | -27.01% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
Don't forget to follow the news on BIOPHYTIS. At the time of publication of this analysis, the latest news was as follows:
- BIOPHYTIS Announces Successful Completion of SARA-PK Clinical Study for Sarconeos in Sarcopenia Confirming Safety Profile
- BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients
- BIOPHYTIS Presenting Four Posters on Sarconeos at 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting
- BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis BIOPHYTIS - Daily